Thalidomide-based maintenance therapy following autologous stem-cell transplantation (ASCT) in multiple myeloma is the focus of an important study by Spencer and colleagues. 1 The use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback